Barclays’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-50
| Closed | – | – | 4741 |
|
|
2018
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 4702 |
|
|
2018
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 4645 |
|
|
2018
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 4617 |
|
|
2017
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 4378 |
|
|
2017
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 4328 |
|
|
2017
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 4349 |
|
|
2017
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 4336 |
|
|
2016
Q4 | $0 | Hold |
50
| – | – | ﹤0.01% | 4216 |
|
|
2016
Q3 | $0 | Hold |
50
| – | – | ﹤0.01% | 4274 |
|
|
2016
Q2 | $0 | Hold |
50
| – | – | ﹤0.01% | 4158 |
|
|
2016
Q1 | $0 | Hold |
50
| – | – | ﹤0.01% | 4001 |
|
|
2015
Q4 | $0 | Buy |
+50
| New | – | ﹤0.01% | 4326 |
|
|
2014
Q4 | – | Sell |
-414
| Closed | – | – | 4619 |
|
|
2014
Q3 | $0 | Sell |
414
-3
| -0.7% | – | ﹤0.01% | 4636 |
|
|
2014
Q2 | $17K | Hold |
417
| – | – | ﹤0.01% | 3486 |
|
|
2014
Q1 | $17K | Hold |
417
| – | – | ﹤0.01% | 3627 |
|
|
2013
Q4 | $0 | Hold |
417
| – | – | ﹤0.01% | 4598 |
|
|
2013
Q3 | $33K | Sell |
417
-4,122
| -91% | -$326K | ﹤0.01% | 3344 |
|
|
2013
Q2 | $352K | Buy |
+4,539
| New | +$352K | ﹤0.01% | 2415 |
|